SY, C., JY, C., WC, H., THK, P., P, C. K., JS, C., . . . T, S. G. (2022). Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: A meta-analysis. European journal of endocrinology, 187(6), S47. https://doi.org/10.1530/EJE-22-0375
Chicago Style (17th ed.) CitationSY, Chen, Chen JY, Huang WC, Puar THK, Chin Kek P, Chueh JS, Lin YH, Wu VC, and Study Group T. "Cardiovascular Outcomes and All-cause Mortality in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Meta-analysis." European Journal of Endocrinology 187, no. 6 (2022): S47. https://doi.org/10.1530/EJE-22-0375.
MLA (9th ed.) CitationSY, Chen, et al. "Cardiovascular Outcomes and All-cause Mortality in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Meta-analysis." European Journal of Endocrinology, vol. 187, no. 6, 2022, p. S47, https://doi.org/10.1530/EJE-22-0375.